Innovate Finance welcomes today’s launch of the Patient Capital Review Consultation. Having the right funding ecosystem will help the UK’s innovative start-ups grow into world-leading businesses that compete on a global stage.

Currently the lack of effective supply of capital continues to hold some UK firms back from scaling and commercialising this innovation successfully. As we exit the European Union’s funding frameworks such as the EIF, having the right tax incentives and policy leavers will be more important than ever. This review should use this opportunity to look at the entire funding escalator to ensure UK firms can scale here and compete globally.